for Sep 18, 2020
Do you miss travel? I miss travel. But 2 new papers in @CDCgov's journal Emerging Infectious Diseases point out why some of us are unlikely to take to the air for while. #Covid19 transmission on planes. https://t.co/C9VDhInQQe and https://t.co/RF7b9Bl43S
— Helen Branswell (@HelenBranswell) September 18, 2020
A man to match the job. "Atlas, a neuroradiologist who has no training in infectious diseases, public health or epidemiology, recently joined the White House coronavirus task force" https://t.co/prxTmeOy65
— Harry Shearer (@theharryshearer) September 18, 2020
🔥Very Interesting🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 18, 2020
A new large retrospective study suggests that piperacillin/tazobactam + teicoplanin is associated with a higher prevalence of AKI compared with monotherapy.#IDTwitter #JACnews @BSACandJAC https://t.co/7gLPAZwq5F pic.twitter.com/777frhtXzX
Bacterial communities in fungus gardens play a pivotal role in alleviating the effect of plant secondary compounds on the leaf-cutter ant system. @mBioJournal https://t.co/zzY8xohq1S pic.twitter.com/UAVBMTvMxa
— ASM (@ASMicrobiology) September 18, 2020
Heard a radio interview with @hans_kluge yesterday talking about “covid fatigue”. I am feeling this amongst colleagues and outside of work. Now is the time to encourage one another and redouble our efforts to prevent #coronavirus spread #HandsFaceSpace https://t.co/hapNndGUl4
— Jon Otter (@jonotter) September 18, 2020
Fast #coronavirus tests: what they can and can't do.
— Microbes&Infection (@MicrobesInfect) September 18, 2020
Rapid antigen tests are designed to tell in a few minutes whether someone is infectious.
Good article summarizing advantages of different #COVID19 tests (PCR, rapid antigen, antibody tests).https://t.co/RNRJybRfcH pic.twitter.com/Za5QhhGoQ7
Early Release - Case-Control Study of Use of Personal Protective Measures and Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Thailand - Volume 26, Number 11—November 2020 - Emerging Infectious Diseases journal - CDC https://t.co/BzS4TSk7uJ via @CDCgov
— Buddha Basnyat (@BasnyatBuddha) September 18, 2020
Researchers developed a new method to determine how effective 2 antibiotics combined can be in stopping bacterial growth.
— Microbes&Infection (@MicrobesInfect) September 18, 2020
The new method is simple for labs to use & can provide greater scope for customizing treatment of bacterial infections.https://t.co/5VHwXU9Oro
Honored to find out that @GHCC_news has selected me as one of the 50 Most Influential Latinos in GA https://t.co/VNQXSYUOE7
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
Understanding Mexican health worker COVID-19 deaths https://t.co/Z905bcbSZw. Great comments by @BrendaCrabtreeR
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
Moderna and Pfizer Reveal Secret Blueprints for Coronavirus Vaccine Trials https://t.co/X2a0KDnYIW
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
Infectious diseases experts say high recovery is a useless statistic and should not be used. @CDDEP #COVID19vaccine
— BloombergQuint (@BloombergQuint) September 18, 2020
Read more: https://t.co/5GCDqeFP61 pic.twitter.com/nhwdlwCqpS
'New high-speed test shows how antibiotics combine to kill bacteria' #StopSuperbugs https://t.co/pAnDv3ZekX via @UU_University @EurekAlert
— Antibiotic Action (@TheUrgentNeed) September 18, 2020
Damning evidence of political subversion of @CDCgov science from @apoorva_nyc https://t.co/HamZQaKGUi
— Tim Lahey (@TimLaheyMD) September 18, 2020
Lactate is produced by many gut bacteria, and its accumulation in the colon is an indicator of microbiota perturbation. Research reported in @mSystemsJ finds that communities with low numbers of lactate-utilizing bacteria are less stable. https://t.co/wQk47oVghl pic.twitter.com/cnIm7qpcQA
— ASM (@ASMicrobiology) September 18, 2020
NEWS SCAN: #COVID19 hospitalization risk factors; SARS-CoV-2 in wastewater; UK antibiotic resistance response; New #polio cases in 6 nationshttps://t.co/laPNGLbWSA #AntibioticStewardship #AMR
— CIDRAP (@CIDRAP) September 18, 2020
“As global consumption of #antibiotics in both humans and animals has increased and the #antibiotic pipeline has dried up, #antimicrobial resistance is increasingly putting modern medicine under threat,” @OBShealth experts write. https://t.co/YMNooTiDId
— Save Antibiotics (@saveantibiotics) September 18, 2020
Contrary to what fat hysterics desperately want to believe, face diapers won't protect them from a lifetime of suicidal junk-eating. But obstructing the respiratory system all day will have negative effects on a majority of people forced to wear them.https://t.co/BVQ6Hs6R7b pic.twitter.com/OGHVZbk90K
— Saifedean.com (@saifedean) September 18, 2020
Genetic and epidemiologic evidence for in-flight #SARS-CoV-2 transmission from Boston to Hong Kong in March 2020.
— Jonathan Epstein (@EpsteinJon) September 18, 2020
In-Flight Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 - Emerging Infectious Diseases journal - CDC https://t.co/sfiSjA2ul4 via @CDCgov
🔥Breaking news🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 18, 2020
Roche phase III EMPACTA RCT met its 1ry endpoint,showing that patients with severe #COVID19 pneumonia +SOC were 44% less likely to progress to mechanical ventilation or death vs placebo +SOC
No # in mortality
Needs to see effect Vs DExa https://t.co/1uPnC9ysYi
#PenicillinAllergy Testing endorsed by @AAAAI_org and @IDSAInfo as a recommended mandatory #AMS intervention. Maybe we need the same in #AUS @NCAS_Aus @ASIDANZ @ascia_news ? #IDtwitter @CAAR_Aus https://t.co/IWvc7RFshN
— Jason Trubiano 🆔 (@TrubianoJason) September 18, 2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients - International Journal of Infectious Diseases. I am sure Dr. Henry will read this but insist we know there's no need for masks in class and no need for distancing. @PHSAofBC https://t.co/bqQ2zGFTea
— Salim Jiwa (@realreporter) September 18, 2020
Sign up for our online course on #AMS: Managing Antibiotic Resistance! Gain an in-depth knowledge on how antimicrobial stewardship can help slow down #ABR.
— BSAC (@BSACandJAC) September 18, 2020
The course is available in 5 different languages - join learners from across the world!#AbxStewardhttps://t.co/CISevcFF9R pic.twitter.com/F3KTRyOylA
The septum of Staphylococcus warneri is composed of two layers that divide with the “popping” mechanism. The peptidoglycan on the inner surface of the double layered septum is organized into concentric rings. @JBacteriology https://t.co/f2QFXgMLPW pic.twitter.com/BHtMh6NS5I
— ASM (@ASMicrobiology) September 18, 2020
“You don’t want to get exposed to COVID-19 when you’re sick from another virus…the more immunosuppressed you are, the worse off you are to fight off COVID-19.” @DrJeanneM explains why getting your flu shot has never been so important: https://t.co/ef7ILQeP7t pic.twitter.com/dGRfUWU60X
— IDSA (@IDSAInfo) September 18, 2020
🔥🔥NEW🔥🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 18, 2020
Droplets and Aerosols generated by singing and the risk of #COVID19 for choirs.
These results points toward the possibility of COVID-19 spread by small airborne droplets during singing. @EricTopol https://t.co/8EFXCXYCvC pic.twitter.com/zezRLIXpgk
Could the pandemic be sparing Africa? The huge gap in antibody data, official cases & death count is puzzling. Could Africa’s youthfulness or the regular exposure to infectious diseases be protecting it?
— YALDA Africa (@yaldafrica) September 18, 2020
Read more: https://t.co/b5X41hJCxl#YALDACares#COVID19#coronavirus
More than half of patients hospitalized with suspected #COVID19 in Michigan during the peak of the pandemic received #antibiotics soon after they arrived—but many didn’t have bacterial infections. https://t.co/Yfx89ZVnHw
— Save Antibiotics (@saveantibiotics) September 18, 2020
Decreased Influenza Activity During the COVID-19 Pandemic ... https://t.co/7JY8hsIUVf via @CDCgov. There was a 61% decrease respiratory specimens sent for influenza testing and a 98% decrease in test positivity during the COVID-19 pandemic period (March 1–May 16).
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
The VirS membrane sensor protein in Clostridium perfringens is a receptor for the AgrD-derived signaling peptide. Both the VirSR and Agr-like quorum sensing system regulate the production of several toxins. @mBioJournal https://t.co/vZ8AWKQ2Wv pic.twitter.com/zGTP6QXlie
— ASM (@ASMicrobiology) September 18, 2020
@DukeMargolis researchers have released a new report on how to incentivize the development, stewardship and availability of new #antibiotics to combat rising antimicrobial resistance #AMR #PublicHealth #Policy #Researchhttps://t.co/J9AqOKcDzf
— Duke-Margolis (@DukeMargolis) September 18, 2020
A paper published in March explores the balancing act of treating #sepsis while adhering to #antimicrobialstewardship practices. To learn why the authors believe #AntibioticStewardship programs are critical in the ICU, visit #biomerieuxconnection. https://t.co/sgSQxgzXKI
— bioMérieux USA (@bioMerieuxUSA) September 18, 2020
Dr. Anthony Fauci, the nation's leading infectious diseases expert, said that President Trump and Centers for Disease Control director Robert Redfield were "both right" about the distribution timeline for a coronavirus vaccine. https://t.co/Hghc1TTgTR
— CBS This Morning (@CBSThisMorning) September 18, 2020
Study warns of pairing #azithromycin with drugs that affect heart rhythm (those receiving the antibiotic as well as drugs that prolong the QT interval had a 40% higher rate of cardiac events compared with amoxicillin)https://t.co/e5M9JIBC1X #AMR #COVID19
— CIDRAP (@CIDRAP) September 18, 2020
CDC Virus Testing Guidance Was Posted Against Scientists’ Objections by @apoorva_nyc
— Andrew Morris (@ASPphysician) September 18, 2020
nb: in ON, we are not encouraging the same messaging—we are saying if asymptomatic AND no increased risk for COVID or pub health directive, don’t get tested. https://t.co/qE3f40lYlO
IDSA & over 90 other health organizations wrote to @US_FDA today, urging that the agency ensure that COVID-19 vaccine candidates meet all regulatory standards prior to authorization or licensure.
— IDSA (@IDSAInfo) September 18, 2020
The 📄: https://t.co/1q8PgsJPNe
Our news release: https://t.co/iqVdVB6OGq
🔥CDC Update🔥
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 18, 2020
Due to the significance of asymptomatic & pre-symptomatic transmission, this guidance further reinforces the need to test asymptomatic persons, including close contacts of a person with documented SARS-CoV-2 infectionhttps://t.co/5Da0r7nMAd
I want to welcome to Twitter the @EmoryInfectDis Division and invite those interested in Inf Diseases to follow it. In the mean time if you are applying to Adult ID fellowship this year, watch this video and realize why #OnlyAtEmory https://t.co/UEgqA1MXX1
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomised controlled trial - ScienceDirect https://t.co/VOIEmmdZ7r
— Aurélien Dinh (@aurdinh) September 18, 2020
Britain considering whether to impose a 2nd national lockdown, after new #COVID19 cases almost doubled to 6,000 per day, hospital admissions rose & infection rates soared across parts of northern England and London.https://t.co/fkUB0HKWQv #coronavirus pic.twitter.com/fh52PxQQML
— Microbes&Infection (@MicrobesInfect) September 18, 2020
Improved binding of #SARSCoV2 Envelope protein to tight junction-associated PALS1 could play a key role in #COVID19 pathogenesishttps://t.co/YNAcknE269 #coronavirus pic.twitter.com/hzlTjEoJis
— Microbes&Infection (@MicrobesInfect) September 18, 2020
Reducing Staphylococcus aureus resistance to lysostaphin using CRISPR-dCas9. https://t.co/x0a5fqqjbk
— AntibioticResistance (@AntibioticResis) September 18, 2020
The rise of #antibiotic-resistant infections could be one of the most concerning wider health impacts of the #COVID19 pandemic, @wellcometrust’s Gemma Buckland-Merrett explains. https://t.co/4Qbn88QFBn
— Save Antibiotics (@saveantibiotics) September 18, 2020
Early Release - In-Flight Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 - Volume 26, Number 11—November 2020 - Emerging Infectious Diseases journal - CDC https://t.co/57AjuMpi0I
— ρσкяαтн нαηѕαѕυтα แอคหลุม อย่าฟอล อย่าฟาด (@pokrath) September 18, 2020
granulocytic signature identifies COVID-19 and its severity | The Journal of Infectious Diseases | Oxford Academic#nostorm@thankthe team https://t.co/lkHA6TOyFp
— Marc Leone (@MarcLeone8) September 18, 2020
Nice beeb article on the rather cool #dnanudge #covid19 #coronavirus https://t.co/ODlhM0uTk8
— Jon Otter (@jonotter) September 18, 2020
Phase III tocilizumab (EMPACTA) study released by press release showed it did not reduce mortality but reduced the likelihood of needing mechanical ventilation in hospitalised patients w/ COVID-19.
— Andrew Morris (@ASPphysician) September 18, 2020
We need the peer-reviewed manuscript (not yet submitted). https://t.co/AUqd5zS6pa
The reporting actually allowed CDC to post their actual science-based recommendations today! A win for journalism and a step forward. #unchainCDC Emails Detail Effort to Silence C.D.C. and Question Its Science https://t.co/Kip1sBQDPT
— Andrew Pavia (@AndrewPaviaMD) September 18, 2020
You Need a Test: CDC Reverses Guidance for Asymptomatic COVID Contacts https://t.co/B5BnUwG0t8 Not testing asymptomatic contacts for #COVID19 make ZERO sense scientifically and my advice was "ignore the CDC guidance". Now I can say again "read the CDC testing guidance"
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
We need an integrated public health approach with comprehensive measures and enabling environment under the purview of National AMR Programmes or their equivalents. @WHO is currently developing a policy on integrated #Antimicrobialstewardship activities to assist this. Stay tuned https://t.co/zQzKDseSDr
— Haileyesus Getahun MD, MPH, PhD. (@hygetahun) September 18, 2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients – via International Journal of Infectious Diseaseshttps://t.co/xUqL7beIA4
— LinksMedicus.com (@Links_Medicus) September 18, 2020
Results from 3 new studies: "#COVID19 likely spreading from people to animals—and vice versa" (the authors of one study say those with COVID should isolate from people AND animals)https://t.co/cHIbzY1FAX pic.twitter.com/rYsPqTgjRr
— CIDRAP (@CIDRAP) September 18, 2020
And Chris Witty, he’s interesting. His specialty is infectious diseases, malaria. Not viruses. Have a look at his publicationshttps://t.co/8U7sJlciDp
— The Moon (@TheMoon53726841) September 18, 2020
Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee | Infectious Diseases | JAMA | JAMA Network https://t.co/vHRj4W75SE
— wacho aleman (@waleman64) September 18, 2020
A new episode of PharmCast is out now! This month, Dr. Daniel Chastain, UGA CoP Clinical Assistant Professor and Clinical Pharmacy Specialist in Infectious Diseases, discusses access to vaccines and how influenza interacts with COVID-19.
— UGA College of Pharmacy (@UGAPharmacy) September 18, 2020
Tune in: https://t.co/Bxgvy9XYKf
A new perspective article in JID proposes how to prioritize allocation of #COVID19 vaccines when initial supplies are limited, accounting for epidemiology, vaccinology, bioethics and racial disparities: https://t.co/yhv0Rna3RH #JInfectDis #IDSAJournals
— IDSA (@IDSAInfo) September 18, 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial | Infectious Diseases | JAMA | JAMA Network https://t.co/cOIy27WnEN
— wacho aleman (@waleman64) September 18, 2020
Excellent study by @grahamscooke & colleagues showing potential utility of CovidNudge in POC diagnosis of #COVID19. Overall 94% sensitivity and 100% specificity c/f lab-based testing very encouraging in this first analysis. https://t.co/UDfYNExRBR
— Marc Mendelson (@SouthAfricanASP) September 18, 2020
Heavy exposure of children aged 9 to 12 years with SARS-CoV-2 did not lead to infection | Journal of the Pediatric Infectious Diseases Society | Oxford Academic https://t.co/aGssZQ8YgP
— Omid Vafa (@VafaOmid) September 18, 2020
Over 1/2 of patients & staff with #COVID19 monitored by an Irish hospital suffered persistent fatigue in the aftermath of the initial disease, according to a new study highlighting the "significant burden" of lingering symptoms.https://t.co/RJJmM8Zsch #coronavirus
— Microbes&Infection (@MicrobesInfect) September 18, 2020
Early Release - Case-Control Study of Use of Personal Protective Measures and Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Thailand - Volume 26, Number 11—November 2020 - Emerging Infectious Diseases journal - CDC https://t.co/4OPrnNQodU @CDCgovより
— どっぺるさん🐈 (@doppel_surg) September 18, 2020
It's back-to-school week - either in-person or virtually - for #Massachusetts school children. Chief of Infectious Diseases Dr. @hboucher3 shares advice on how kids can stay healthy and prevent #coronavirus transmission this school year. https://t.co/qT8aKcALYh @WCVB #COVID19
— Tufts Medical Center (@TuftsMedicalCtr) September 18, 2020
The situation update on #coronavirus has been updated on our website (18 September at 16:20).
— THL (@THLorg) September 18, 2020
🔹Samples tested: approx. 866,100
🔹Reported cases: 8,858
🔹Recovered: approx. 7,700
🔹Hospitalised: 16
🔹In intensive care: 3
🔹Deaths: 339
Read more 👇 https://t.co/sdGQYvL8Wx
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients - International Journal of Infectious Diseases @fnpmuhendislik #Airborne https://t.co/9NXjmOtrzq
— Yonca Bulut M.D.👩🏻⚕️ (@yoncabulutmd) September 18, 2020
Shout out to @Clin_Chem_AACC for putting this cool video feature together on some of the clinical pearls of antifungals presented by our previous fellow @Xinergistic 🤓 @PrecisionAbxLab @UICPhPr https://t.co/KQ1D7jGTOA
— Eric Wenzler (@TheIDApprentice) September 18, 2020
Tal y como se ha descrito para otros betacoronavirus👇🏻👇🏻👇🏻👇🏻Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee | Infectious Diseases | JAMA | JAMA Network https://t.co/LGMp7SR9Ar
— SciArt3D (@SciArt3D) September 18, 2020
Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process - PubMed#borreliose #lymedisease #conflitsinterets #recommandations #medtwitter #CNGE #SPILF #acadmed #ReJIF_ #AfSocAN #lyme https://t.co/FTJ0OKQTSw
— Calamity Lyme (@calamity_lyme) September 18, 2020
Dr Anthony Fauci has also awarded 11 grants to establish Centers for Research in Emerging Infectious Diseases (CREID), a global network to investigate how & where viruses & other pathogens emerge from wildlife & spillover to cause disease in people. https://t.co/CGscbOL8vX pic.twitter.com/JpjMXdN35w
— Truth (@1foreverseeking) September 18, 2020
Dr. Justin Hayes, medical director of antimicrobial stewardship, will discuss fundamental and contemporary concepts in antimicrobial stewardship as well as the current challenges associated with the COVID-19 pandemic.https://t.co/QKpJ9VTEbI
— University of Arizona- Infectious Disease Division (@UAZDivID) September 18, 2020
Wed., Sept 23rd. Medicine Grand Rounds pic.twitter.com/VzDofpoIps
For my Seattle/King County peeps. A lot riding on the election, but an important local vote is Prop 1 #HarborviewHealthForAll. @Harborviewmc is here for everyone and we need your vote to get the $$ for a new hospital/respite/BH https://t.co/PJhGQ5cckM pic.twitter.com/IfdGFfHK48
— John Lynch (@JohnLynchID) September 18, 2020
Thanks to @NKaslow for writing this thoughtful editorial in #CID about the association between PPE availability and emotional wellness for healthcare professionals during #COVID19 https://t.co/oqmMvm7M8f
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
China continuing its exemplary success at handling infectious diseases. 🤔
— 🇬🇧 ℙ𝕒𝕦𝕝 🇬🇧 (@PaulLeMay16) September 18, 2020
China outbreak: Thousands infected with bacterial disease after bio factory leak | World | News | https://t.co/GCKmUarfB2 https://t.co/StgBpdwf5p
I’m so embarrassed. It ought to be known that the Brazilian Societies of Pneumology and of Infectious Diseases favored stronger responses. https://t.co/GYdv6bVuaf
— Nava Rodrigues, D (@daninava) September 18, 2020
Really interesting study->Antibiotics Differentially Modulate Lipoteichoic Acid-Mediated Host Immune Response to S. aureus#Vancomycin->anti-inflammatory (increased IL-10)
— Sarah Jorgensen 🌈🎶🇨🇦 (@canuckIDpharm) September 18, 2020
Tedizolid->pro-inflammatory (increased TNFα, HLA-DR) Daptomycin largely no effect https://t.co/75cCVVZ3T8
Things are moving on the #Coronavirus front here in England. I’ve been saying to anyone who’ll listen over the summer that we’re likely to see more #covid19 in the autumn and winter, but hoping it wouldn’t be so! https://t.co/FhUaFCUPJA
— Jon Otter (@jonotter) September 18, 2020
Good guy to be a coronavirus advisor: "Atlas... does not have a background in infectious diseases or epidemiology" https://t.co/sdVY5mNgqi
— Harry Shearer (@theharryshearer) September 18, 2020
But he's probably an ace at fixing your muffler.
Environmental structure drives resistance to phages and antibiotics during phage therapy and to invading lysogens during colonisation. https://t.co/sT0YBH2XZQ
— AntibioticResistance (@AntibioticResis) September 18, 2020
.@NIDAnews Director Dr. Volkow co-author in this study looking at #COVID19 risk and outcomes in persons with SUD. Black with SUD are at 4x⬆️risk for COVID than Whites as well as worse outcomes https://t.co/xsW01uP8Tu
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
Clinical bioinformatics for microbial #genomics and metagenomics:
— Microbes&Infection (@MicrobesInfect) September 18, 2020
An ESCMID Postgraduate Technical Workshophttps://t.co/JrtkSDNznm #microbiology pic.twitter.com/XqqO78rO50
Emails Detail Effort to Silence @CDCgov and Question Its Science via @NYTimes https://t.co/S9CJJh64Rw
— Carlos del Rio (@CarlosdelRio7) September 18, 2020
Moderna and Pfizer Reveal Secret Blueprints Trials - The New York Times | @scoopit https://t.co/ftGnBEiN1d#coronavirus #COVID19 #health #globalhealth #publichealth #medicine #biotechnology #pharmaceuticals #infectiousdiseases #pandemic #outbreak #FDA #WHO #CDC #vaccines
— RetroVirox (@RetroVirox) September 18, 2020
The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelines - PubMed#borreliose #lymedisease #medtwitter #conflitsinterets #recommandations #CNGE #SPILF #acadmed #ReJIF_ #AfSocAN https://t.co/NMvMHGYWbt
— Calamity Lyme (@calamity_lyme) September 18, 2020
before getting the flu https://t.co/lsSaSKfhXl a Sept. 10 interview with actor Jennifer Garner on Instagram Live, the director of the National Institute of Allergy and Infectious Diseases (NIAID) said that he gets the flu vaccine in mid- to late October, and recommended that
— Arya McCrazy😜 Irish/Japanese, Beer Swilling Ninja (@river_arya) September 18, 2020
Laurie Blankenship, PharmD, of Park City Hospital at @Intermountain, uses VigiLanz every day to support #patientcare. One of the key benefits: Faster identification of potential problems and quicker interventions when necessary. https://t.co/01XKVWI2nV pic.twitter.com/M7asABOBoS
— VigiLanz (@vigilanzcorp) September 18, 2020
White House coronavirus adviser Scott Atlas has threatened to doctors who say he’s not qualified for the job because.he lacks a background in public health, epidemiology or infectious diseases. He has specialized in radiology and neuroradiology. https://t.co/LkR7fAe52I
— Paul Farhi (@farhip) September 18, 2020
Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection | Infectious Diseases | JAMA Ophthalmology | JAMA Network https://t.co/T9wzs9KVnJ
— imuinelo (@imuinelo) September 18, 2020
Check out my latest article: Coronavirus: is this the start of a second wave and are we ready? https://t.co/u2hWYsxivU via @LinkedIn #UnitedKingdom #England #Scotland #Wales #NorthernIreland #Europe #Infectiousdiseases #epidemiology #virus #Pandemic #Corona #CoronaVirus #Covid-19
— chemistrychrisa (@ChemistryChrisA) September 18, 2020
Lockdowns and other tough measures implemented to fight the COVID-19 pandemic have led to a dramatic decline in other infectious illnesses such as influenza and sexually transmitted infections, public health data suggest https://t.co/1gJWgjaXT9 pic.twitter.com/v6EJ2rxZBU
— NEWS 1130 (@NEWS1130) September 18, 2020
The latest The antimicrobial stewardship Daily! https://t.co/4TSw8ALd2N Thanks to @AyodejiMatuluko @PatientsAssoc @AVMAvets #sepsis #ams
— Abid Hussain (@MicrobLog_me_uk) September 18, 2020
Americans increasingly skeptical of COVID vaccine, poll finds (and the CDC reverses itself on testing guidance)https://t.co/j8uKvS8XuQ pic.twitter.com/ctmRUc705x
— CIDRAP (@CIDRAP) September 18, 2020
Even a third of Americans getting vaccinated against the coronavirus won’t be enough, the director of the National Institute of Allergy and Infectious Diseases said.
— ABC 17 News (@ABC17News) September 18, 2020
https://t.co/XDFbhlldel
https://t.co/oOfJxK8L7f
— 💥💥💥💥💥⓵ⒷⓊⓋ💥💥💥💥💥 (@_1BUV) September 18, 2020
(Natural News)
Retired U.S. Army Reserve Col. Lawrence Sellin (Ret.) has penned an article calling for a full investigation into the National Institute of Allergy and Infectious Diseases (NIAID), its leader Anthony Fauci, and the communist ...
the virus is non highly infectious - next to no one has had the virus and next to no one has died from ithttps://t.co/snAROwtiRh
— Query Everything (@QueryTheLot) September 18, 2020
Dr. Anthony Fauci, the nation's leading infectious diseases expert, said that President Trump and Centers for Disease Control director Robert Redfield were "both right" about the distribution timeline for a coronavirus vaccine. https://t.co/N4LHeqbvvn
— WJZ | CBS Baltimore (@wjz) September 18, 2020
Honored to present Pediatric Grand Rounds on antimicrobial stewardship in immunocompromised kids at @UCLAHealth this morning. pic.twitter.com/wGB5b0neIq
— Josh Wolf (@Joshuawolf) September 18, 2020
Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China - Volume 26, Number 9—September 2020 - Emerging Infectious Diseases journal - CDC https://t.co/FNdTMHm7Ck via @CDCgov
— 𝓝𝓸𝓼𝓯𝓮𝓻𝓪𝓽𝓾 (@FourWinns298) September 18, 2020
Our response to the Sept. 18 @CDCgov Testing Overview Revisions (https://t.co/bs6etyyVqD). pic.twitter.com/bbbXBEHfrs
— IDSA (@IDSAInfo) September 18, 2020
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 - International Journal of Infectious Diseases https://t.co/FoMy1oVFCz
— Linda R Oliver (@LindaROliver3) September 18, 2020
Devastating picture of Trump’s coronavirus response from a firsthand witness https://t.co/7k49d2dPwH
— Tim Lahey (@TimLaheyMD) September 18, 2020
How did herd immunity enter the language of public health? The phrase seems to have first appeared in the work of American livestock veterinarians concerned about “contagious abortion”—epidemics of spontaneous miscarriage—in cattle and sheep. #COVID19 https://t.co/FzAJavckKn
— Antibiotic Steward🆔 Bassam Ghanem (@ABsteward) September 18, 2020
Prior Zika virus infection increases risk of severe dengue disease https://t.co/7H1SYZvDDN #zika #infectiousdiseases pic.twitter.com/UUMVJsu9UW
— BiotechBioPharma (@Regencells) September 18, 2020
The joint @ECDC_EU and @EMCDDA guidance on Prevention and control of infectious diseases among people who inject drugs is currently being updated. They re inviting applications to report models of good practice targeting PWID population.https://t.co/lE0HauMTk6 pic.twitter.com/zAD4HYYnQe
— DPNSEE (@DPN_SEE) September 18, 2020
Created by Cameron Forbes. Last updated September 19, 2020 at 05:08 EST.